The University of Southampton
University of Southampton Institutional Repository

DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies

DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies
DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies
Antibody-Drug Conjugates (ADCs) are growing in importance for the treatment of both solid and haematological malignancies. There is a demand for new payloads with novel mechanisms of action that may offer enhanced therapeutic efficacy, especially in patients who develop resistance. We report here a class of Cyclopropabenzindole-Pyridinobenzodiazepine (CBI-PDD) DNA cross-linking payloads that simultaneously alkylate guanine (G) and adenine (A) bases in the DNA minor groove with a defined sequence selectivity. The lead payload, FGX8-46 (6), produces sequence-selective G-A cross-links and affords cytotoxicity in the low picomolar region across a panel of 11 human tumour cell lines. When conjugated to the antibody cetuximab at an average Drug-Antibody Ratio (DAR) of 2, an ADC is produced with significant antitumour activity at 1 mg/kg in a target-relevant human tumour xenograft mouse model with an unexpectedly high tolerability (i.e., no weight loss observed at doses as high as 45 mg/kg i.v., single dose).
2399-3642
Procopiou, George
4a8347c7-8dc2-41d3-a0d0-5e5036819813
Jackson, Paul J. M.
a8f66bdd-98e9-43c7-b6c2-753659dc60e1
Auer, Jennifer
d9478a93-7b4c-46cc-9d64-e657bf9f91e4
Di Mascio, Daniella
915ed5fb-e344-42eb-bca6-86b52e5200e8
Pepper, Chris
d98085c8-4674-4a8e-9698-cff8194440e1
Miraz Rahman, Khondaker
6f57e1a3-b2d4-42a3-89f1-2344f515e6cd
Fox, Keith
9da5debc-4e45-473e-ab8c-550d1104659f
Thurston, David E.
9e2a56ac-259f-4977-a087-9d97c9003fbb
Procopiou, George
4a8347c7-8dc2-41d3-a0d0-5e5036819813
Jackson, Paul J. M.
a8f66bdd-98e9-43c7-b6c2-753659dc60e1
Auer, Jennifer
d9478a93-7b4c-46cc-9d64-e657bf9f91e4
Di Mascio, Daniella
915ed5fb-e344-42eb-bca6-86b52e5200e8
Pepper, Chris
d98085c8-4674-4a8e-9698-cff8194440e1
Miraz Rahman, Khondaker
6f57e1a3-b2d4-42a3-89f1-2344f515e6cd
Fox, Keith
9da5debc-4e45-473e-ab8c-550d1104659f
Thurston, David E.
9e2a56ac-259f-4977-a087-9d97c9003fbb

Procopiou, George, Jackson, Paul J. M., Auer, Jennifer, Di Mascio, Daniella, Pepper, Chris, Miraz Rahman, Khondaker, Fox, Keith and Thurston, David E. (2022) DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies. Communications Biology, 5 (1), [741]. (doi:10.1038/s42003-022-03633-0).

Record type: Article

Abstract

Antibody-Drug Conjugates (ADCs) are growing in importance for the treatment of both solid and haematological malignancies. There is a demand for new payloads with novel mechanisms of action that may offer enhanced therapeutic efficacy, especially in patients who develop resistance. We report here a class of Cyclopropabenzindole-Pyridinobenzodiazepine (CBI-PDD) DNA cross-linking payloads that simultaneously alkylate guanine (G) and adenine (A) bases in the DNA minor groove with a defined sequence selectivity. The lead payload, FGX8-46 (6), produces sequence-selective G-A cross-links and affords cytotoxicity in the low picomolar region across a panel of 11 human tumour cell lines. When conjugated to the antibody cetuximab at an average Drug-Antibody Ratio (DAR) of 2, an ADC is produced with significant antitumour activity at 1 mg/kg in a target-relevant human tumour xenograft mouse model with an unexpectedly high tolerability (i.e., no weight loss observed at doses as high as 45 mg/kg i.v., single dose).

Text
s42003-022-03633-0 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 24 June 2022
Published date: 29 July 2022
Additional Information: Funding Information: All authors except C.P. are either paid employees/consultants (G.P., P.J.M.J., D.E.T.) or recipients of grants funded by Femtogenix Ltd (D.d.M, K.R.F.). G.P., P.J.M.J., K.M.R and D.E.T. hold shares and/or share options in the company. C.P declares no competing interests.

Identifiers

Local EPrints ID: 468976
URI: http://eprints.soton.ac.uk/id/eprint/468976
ISSN: 2399-3642
PURE UUID: c9ffa73b-dab1-49b4-b022-194090aafaa3
ORCID for Keith Fox: ORCID iD orcid.org/0000-0002-2925-7315

Catalogue record

Date deposited: 02 Sep 2022 18:43
Last modified: 17 Mar 2024 02:34

Export record

Altmetrics

Contributors

Author: George Procopiou
Author: Paul J. M. Jackson
Author: Jennifer Auer
Author: Chris Pepper
Author: Khondaker Miraz Rahman
Author: Keith Fox ORCID iD
Author: David E. Thurston

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×